Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$272M |
| 2 |
Chevron
CVX
|
+$206M |
| 3 |
Tesla
TSLA
|
+$153M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Pfizer
PFE
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
First Solar
FSLR
|
+$153M |
| 3 |
Walmart Inc
WMT
|
+$133M |
| 4 |
Steel Dynamics
STLD
|
+$115M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.92% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.68% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Immunome
IMNM
$2.61B
| $122K | ﹤0.01% |
15,433
| – | – |
|
3302
Erasca
ERAS
$6.48B
| $120K | ﹤0.01% |
43,372
-37,004
| -46% | -$105K |
|
3303
Nkarta
NKTX
$154M
| $115K | ﹤0.01% |
52,681
+13,922
| +36% | +$61.2K |
|
3304
Capricor Therapeutics
CAPR
$243M
| $115K | ﹤0.01% |
24,085
-74,112
| -75% | -$326K |
|
3305
McEwen Inc
MUX
$1.06B
| $115K | ﹤0.01% |
15,954
| – | – |
|
3306
Cardlytics
CDLX
$22.1M
| $114K | ﹤0.01% |
+1,802
| New | +$109K |
|
3307
Montauk Renewables
MNTK
$260M
| $113K | ﹤0.01% |
+15,227
| New | +$105K |
|
|
IRD
3308
Opus Genetics
IRD
$317M
| $111K | ﹤0.01% |
25,592
| – | – |
|
|
CZOO
3309
DELISTED
Cazoo Group Ltd
CZOO
| $109K | ﹤0.01% |
918
-6
| -0.6% | -$996 |
|
|
NBP
3310
NovaBridge Biosciences American Depositary Shares
NBP
$190M
| $108K | ﹤0.01% |
36,123
-7,790
| -18% | -$25K |
|
3311
X4 Pharmaceuticals
XFOR
$377M
| $107K | ﹤0.01% |
1,843
-134
| -7% | -$6.89K |
|
|
SLNO
3312
DELISTED
Soleno Therapeutics
SLNO
| $107K | ﹤0.01% |
24,966
-5,173
| -17% | -$22.2K |
|
3313
Q32 Bio
QTTB
$462M
| $106K | ﹤0.01% |
6,679
-862
| -11% | -$15.5K |
|
3314
Alpha Teknova
TKNO
$271M
| $106K | ﹤0.01% |
39,740
-10,200
| -20% | -$27.4K |
|
3315
Aspen Aerogels
ASPN
$374M
| $105K | ﹤0.01% |
13,362
-117,443
| -90% | -$817K |
|
3316
Standard BioTools
LAB
$351M
| $105K | ﹤0.01% |
54,398
-28,215
| -34% | -$55.7K |
|
3317
American Coastal Insurance
ACIC
$515M
| $105K | ﹤0.01% |
23,516
| – | – |
|
3318
Turkcell
TKC
$4.72B
| $103K | ﹤0.01% |
28,927
+1,080
| +4% | +$4.53K |
|
3319
Clover Health Investments
CLOV
$2.29B
| $103K | ﹤0.01% |
114,259
-8,480
| -7% | -$7.52K |
|
|
PPTA
3320
Perpetua Resources
PPTA
$2.37B
| $102K | ﹤0.01% |
27,910
| – | – |
|
3321
Beyond Air
XAIR
$3.91M
| $101K | ﹤0.01% |
59
+22
| +59% | +$50.3K |
|
|
ICVX
3322
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $100K | ﹤0.01% |
+10,109
| New | +$80.9K |
|
3323
QuickLogic
QUIK
$228M
| $99.6K | ﹤0.01% |
10,842
| – | – |
|
3324
Nortech Systems
NSYS
$37.7M
| $99.2K | ﹤0.01% |
10,138
| – | – |
|
|
SALM
3325
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $98.8K | ﹤0.01% |
103,131
-17,615
| -15% | -$17.5K |
|
Similar funds
Dimensional Fund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
- Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
- Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
- Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
- Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.